Overview

Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
VAGINAL PRASTERONE in the treatment of VAGINAL ATROPHY IN PATIENTS WITH BREAST CANCER TREATMENT WITH AROMATASE INHIBITORS (VIBRA STUDY)
Phase:
Phase 4
Details
Lead Sponsor:
Hospital Clinic of Barcelona
Treatments:
Dehydroepiandrosterone